J A Revez1, M C Matheson2, J Hui3,4,5,6, S Baltic7, A James6,8,9, J W Upham10, S Dharmage2, P J Thompson7,8, N G Martin1, J L Hopper2, M A R Ferreira1. 1. QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia. 2. Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Vic., Australia. 3. PathWest Laboratory Medicine of Western Australia (WA), Nedlands, WA, Australia. 4. School of Population Health, The University of WA, Nedlands, WA, Australia. 5. School of Pathology and Laboratory Medicine, The University of WA, Nedlands, WA, Australia. 6. Busselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Perth, WA, Australia. 7. Institute for Respiratory Health, University of WA, Perth, WA, Australia. 8. School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia. 9. Department of Pulmonary Physiology, West Australian Sleep Disorders Research Institute, Nedlands, WA, Australia. 10. School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Qld, Australia.
Abstract
BACKGROUND: Functional variants in the interleukin-6 receptor gene (IL6R) are associated with asthma risk. We hypothesized that genes co-expressed with IL6R might also be regulated by genetic polymorphisms that are associated with asthma risk. The aim of this study was to identify such genes. METHODS: To identify genes whose expression was correlated with that of IL6R, we analyzed gene expression levels generated for 373 human lymphoblastoid cell lines by the Geuvadis consortium and for 38 hematopoietic cell types by the Differentiation Map Portal (DMAP) project. Genes correlated with IL6R were then screened for nearby single nucleotide polymorphisms (SNPs) that were significantly associated with both variation in gene expression levels (eSNPs) and asthma risk. RESULTS: We identified 90 genes with expression levels correlated with those of IL6R and that also had a nearby eSNP associated with disease risk in a published asthma GWAS (N = 20 776). For 16 (18%) genes, the association between the eSNP and asthma risk replicated with the same direction of effect in a further independent published asthma GWAS (N = 27 378). Among the top replicated associations (FDR < 0.05) were eSNPs for four known (IL18R1, IL18RAP, BCL6, and STAT6) and one putative novel asthma risk gene, stomatin-like protein 2 (STOML2). The expression of STOML2 was negatively correlated with IL6R, while eSNPs that increased the expression of STOML2 were associated with an increased asthma risk. CONCLUSION: The expression of STOML2, a gene that plays a key role in mitochondrial function and T-cell activation, is associated with both IL-6 signaling and asthma risk.
BACKGROUND: Functional variants in the interleukin-6 receptor gene (IL6R) are associated with asthma risk. We hypothesized that genes co-expressed with IL6R might also be regulated by genetic polymorphisms that are associated with asthma risk. The aim of this study was to identify such genes. METHODS: To identify genes whose expression was correlated with that of IL6R, we analyzed gene expression levels generated for 373 human lymphoblastoid cell lines by the Geuvadis consortium and for 38 hematopoietic cell types by the Differentiation Map Portal (DMAP) project. Genes correlated with IL6R were then screened for nearby single nucleotide polymorphisms (SNPs) that were significantly associated with both variation in gene expression levels (eSNPs) and asthma risk. RESULTS: We identified 90 genes with expression levels correlated with those of IL6R and that also had a nearby eSNP associated with disease risk in a published asthma GWAS (N = 20 776). For 16 (18%) genes, the association between the eSNP and asthma risk replicated with the same direction of effect in a further independent published asthma GWAS (N = 27 378). Among the top replicated associations (FDR < 0.05) were eSNPs for four known (IL18R1, IL18RAP, BCL6, and STAT6) and one putative novel asthma risk gene, stomatin-like protein 2 (STOML2). The expression of STOML2 was negatively correlated with IL6R, while eSNPs that increased the expression of STOML2 were associated with an increased asthma risk. CONCLUSION: The expression of STOML2, a gene that plays a key role in mitochondrial function and T-cell activation, is associated with both IL-6 signaling and asthma risk.
Authors: Chien-Hsiung Yu; Massimo Micaroni; Andreas Puyskens; Thomas E Schultz; Jeremy Changyu Yeo; Amanda C Stanley; Megan Lucas; Jade Kurihara; Karen M Dobos; Jennifer L Stow; Antje Blumenthal Journal: J Immunol Date: 2015-09-14 Impact factor: 5.422
Authors: Anna L Dixon; Liming Liang; Miriam F Moffatt; Wei Chen; Simon Heath; Kenny C C Wong; Jenny Taylor; Edward Burnett; Ivo Gut; Martin Farrall; G Mark Lathrop; Gonçalo R Abecasis; William O C Cookson Journal: Nat Genet Date: 2007-09-16 Impact factor: 38.330
Authors: Aysefa Doganci; Tatjana Eigenbrod; Norbert Krug; George T De Sanctis; Michael Hausding; Veit J Erpenbeck; El-Bdaoui Haddad; Hans A Lehr; Edgar Schmitt; Tobias Bopp; Karl-J Kallen; Udo Herz; Steffen Schmitt; Cornelia Luft; Olaf Hecht; Jens M Hohlfeld; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Stefan Rose-John; Harald Renz; Markus F Neurath; Peter R Galle; Susetta Finotto Journal: J Clin Invest Date: 2005-02 Impact factor: 14.808
Authors: M Hallek; C Neumann; M Schäffer; S Danhauser-Riedl; N von Bubnoff; G de Vos; B J Druker; K Yasukawa; J D Griffin; B Emmerich Journal: Exp Hematol Date: 1997-12 Impact factor: 3.084
Authors: George Tsirakis; Constantina A Pappa; Maria Kaparou; Anna Boula; Vaitsa Katsomitrou; Athina Xekalou; Stavroula Kyriakaki; Michael G Alexandrakis Journal: Tumour Biol Date: 2012-12-16
Authors: J Müllberg; E Dittrich; L Graeve; C Gerhartz; K Yasukawa; T Taga; T Kishimoto; P C Heinrich; S Rose-John Journal: FEBS Lett Date: 1993-10-11 Impact factor: 4.124
Authors: Gregory A Hawkins; Mac B Robinson; Annette T Hastie; Xingnan Li; Huashi Li; Wendy C Moore; Timothy D Howard; William W Busse; Serpil C Erzurum; Sally E Wenzel; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker Journal: J Allergy Clin Immunol Date: 2012-05-01 Impact factor: 14.290
Authors: Alexis Battle; Sara Mostafavi; Xiaowei Zhu; James B Potash; Myrna M Weissman; Courtney McCormick; Christian D Haudenschild; Kenneth B Beckman; Jianxin Shi; Rui Mei; Alexander E Urban; Stephen B Montgomery; Douglas F Levinson; Daphne Koller Journal: Genome Res Date: 2013-10-03 Impact factor: 9.043
Authors: Ricardo C Ferreira; Daniel F Freitag; Antony J Cutler; Joanna M M Howson; Daniel B Rainbow; Deborah J Smyth; Stephen Kaptoge; Pamela Clarke; Charlotte Boreham; Richard M Coulson; Marcin L Pekalski; Wei-Min Chen; Suna Onengut-Gumuscu; Stephen S Rich; Adam S Butterworth; Anders Malarstig; John Danesh; John A Todd Journal: PLoS Genet Date: 2013-04-04 Impact factor: 5.917